Skip to main content
. Author manuscript; available in PMC: 2025 Jul 1.
Published in final edited form as: Cancer Causes Control. 2024 Apr 1;35(7):1053–1061. doi: 10.1007/s10552-024-01864-6

Table 3.

The Childhood Cancer Risk among Offspring of Mothers with Hypertension before Birth, Stratifying by Medication Use

Hypertension before birth (all types)
Cases (n=2,780) Non-cases (n=2,291,512) Crude HR (95% CI) *Adjusted HR (95% CI)
No diagnosis of hypertension before birth 2,664 2,194,495 1 (ref) 1 (ref)
Maternal hypertension before birth 92 72,656 1.14 (0.93–1.40) 1.12 (0.90–1.41)
 No medications before birth 12 11,403 0.94 (0.53–1.65) 0.98 (0.56–1.73)
 Any medications before birth other than diuretics 54 40,583 1.20 (0.92–1.57) 1.15 (0.86–1.54)
 Diuretics before birth 26 20,670 1.13 (0.77–1.66) 1.16 (0.77–1.74)
Hypertension and diuretic use between conception (0 weeks) and birth 10 8,945 0.98 (0.53–1.83) 0.94 (0.48–1.83)
Hypertension but without diuretic use between conception (0 weeks) and birth 80 63,350 1.13 (0.91–1.42) 1.13 (0.89–1.43)
*

Model adjusted for parity, preeclampsia/eclampsia in the index pregnancy, family income, infections in pregnancy, and hyperthyroidism